Veriheal

JANUARY 24, 2023

As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. So what gives?

DEA 98

DEA Treatment Pets Medicine 98

Cannabis Life Network

FEBRUARY 22, 2023

The Drug Enforcement Administration (DEA) says Delta-8 and -9 THCO are controlled substances, even when derived from hemp. The DEA said that Delta-8 and -9 THCO “do not occur naturally in the cannabis plant and can only be obtained synthetically, and therefore do not fall under the definition of hemp.”

DEA 76

DEA Hemp Cannabinoids Legalization 76

Cannabis Law Report

JUNE 14, 2023

Marijuana Moment The Drug Enforcement Administration (DEA) is weighing in on the legal status of lesser known cannabinoids such as THCA, delta-8 THC and hydrogenated CBD.

DEA 98

DEA Cannabinoids CBD Legalization 98

Veriheal

OCTOBER 20, 2021

Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production.

DEA 98

DEA Cultivation Cannabis Marijuana 98

Cannabis Law Report

SEPTEMBER 1, 2021

Marijuana Moment reports. In its response, the agency argued that marijuana has no currently accepted medical value. Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. In a ruling filed on Monday, the U.S.

DEA 109

DEA Marijuana Policy Cannabis 109

Medical Marijuana Program Connection

DECEMBER 19, 2023

DEA Warns Georgia Against Offering Medical Marijuana at Independent Pharmacies, Citing Federal Law Violation. Drug Enforcement Administration is warning Georgia not to go. Read More

DEA 49

DEA Marijuana Law Cannabis 49

NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 165

DEA Cultivation Compliance Compliance 165

Cannabis Law Report

OCTOBER 27, 2020

A vague memory tells us that the DEA were looking for a contractor early 2019 ? Marijuana Moment has … Read More. The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor.

DEA 98

DEA Law Marijuana Cannabis 98

CannaMD

MARCH 26, 2024

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 97

DEA Marijuana Therapy Policy 97

Cannabis Law Report

MAY 23, 2022

Marijuana Moment reports. Federal marijuana arrests continue to plummet year over year as more states move to legalize cannabis, new data from the Justice Department shows. Federal Marijuana Arrests Continue To Drop Amid Legalization Movement, New Justice Department Report Shows. Read full report.

DEA 59

DEA Data Cannabis Marijuana 59

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

NORML

OCTOBER 21, 2019

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.

DEA 103

DEA Cultivation Clinical Trials Policy 103

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

Cannabis Law Report

MARCH 24, 2020

The USA’s Drug Enforcement Administration and Department of Justice have published a Notice of Proposed Rulemaking regarding scientific and medical research on marijuana. Last September, it indicated it would “facilitate and expand” scientific and medical marijuana research and last week saw another tentative step in that direction.

DEA 80

DEA Marijuana Extraction Strains 80

Cannabis Law Report

DECEMBER 17, 2020

Does marijuana have a currently accepted medical use in the U.S.? The post Two-Thirds of States Recognize Medical Use of Marijuana: DEA Disagrees first appeared on Cannabis Law Report. That is the question in front of the Ninth Circuit currently. On May 21, … Read More.

DEA 86

DEA Marijuana Law Cannabis 86

Cannabis Law Report

SEPTEMBER 24, 2020

DEA Tries to Define Hemp If you’re a hemp business, you probably understand the victory that came with Congress passing the 2018 Farm Bill. The post Hemp Is Not Marijuana. Unless You Ask the DEA first appeared on Cannabis Law Report. As … Read More.

DEA 76

DEA Hemp Marijuana Business 76

Cannabis Law Report

APRIL 14, 2022

A January letter from the Drug Enforcement Agency (DEA) revealed its official stance that marijuana seeds with a delta-9 tetrahydrocannabinol (THC) concentration lower than 0.3% This new guidance establishes that the legality of marijuana seeds, tissue culture, and other genetic material depends solely on delta-9 THC concentration.

DEA 52

DEA THC Hemp Legalization 52

Veriheal

JANUARY 16, 2024

Although there have been rumors circulating for some time regarding the potential rescheduling of cannabis, it wasn’t confirmed until recently that this is becoming a genuine possibility. What Would Rescheduling Mean For Marijuana? Fortunately, it may be happening sooner rather than later. Just last week, the U.S.

DEA 119

DEA Medicine Cannabis Legalization 119

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Less dangerous than marijuana, according to the CSA Schedule, are methamphetamine, cocaine, and hydrocodone. NORML launched the first petition to reschedule marijuana in 1972.

DEA 98

DEA Marijuana History Cannabis 98

Cannabis Law Report

OCTOBER 15, 2021

Marijuana Moment report. The Drug Enforcement Administration (DEA) is proposing a dramatic increase in the legal production of marijuana and psychedelics like psilocybin, LSD, MDMA and DMT to be used in research next year. Marijuana itself would get a 60 percent boost under DEA’s proposal, up to 3.2

DEA 96

DEA Clinical Trials Marijuana Extraction 96

Cannabis Law Report

JUNE 14, 2021

Marijuana Moment reports. Drug Enforcement Administration (DEA) to formally reconsider marijuana’s restrictive federal classification made their case on Thursday to a three-judge panel of the U.S. In its response, the agency argued that marijuana has no currently accepted medical value. Your clients filed no petition.

DEA 97

DEA Marijuana Cannabis Law 97

NORML

JANUARY 16, 2020

Federal prosecutions for marijuana-related crimes fell significantly from September 30, 2018 to September 30, 2019, according to a recently released report from Supreme Court Justice John Roberts. The 2019 end-of-year report finds that the number of federal defendants charged with cannabis-associated crimes declined by 28 percent.

DEA 211

DEA Marijuana Data Cannabis 211

SpeedWeed

MAY 11, 2021

million marijuana plants in 2020, a figure that is up nearly 20% over 2019. The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. The totals include more than 3.7

DEA 52

DEA Marijuana Data Programs 52

Cannabis Life Network

NOVEMBER 8, 2021

In a recently obtained letter, the DEA clarified its position on hemp-derived Delta 8 THC. The post DEA Letter – Delta 8 THC derived from hemp is not a controlled substance appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks. Delta 8 THC made from hemp is legal […].

DEA 87

DEA THC Hemp Legalization 87

Cannabis Law Report

AUGUST 12, 2021

Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. US DEA , No. Read this article from Marijuana Moment for more details on the amicus brief from attorneys general representing eight U.S. I’m honored to be part of the litigation team on the case, AIMS et al.

DEA 105

DEA Medicine Food Patients 105

Cannabis Law Report

AUGUST 12, 2021

Aurum Labs ( [link] ) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration. Aurum has always been at the forefront of cannabis and hemp testing.

DEA 98

DEA Hemp Compliance Compliance 98

NORML

JANUARY 12, 2024

"It is significant for these health agencies to acknowledge publicly, for the first time, what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans."

DEA 313

DEA Marijuana Patients Cannabis 313

Cannabis Law Report

JULY 23, 2021

The Denver cannabis company MedPharm can now ramp up its research into the effects marijuana has on Alzheimer’s disease. The new DEA research license will now change that. It’s possible because of a new Schedule I Researcher License granted by the Drug Enforcement Administration. credit: CBS).

DEA 105

DEA Clinical Trials Cannabinoids Extraction 105

WeedAdvisor

AUGUST 28, 2019

A standoff between marijuana researchers and federal drug enforcement may finally have turned in the scientists’ favour. As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi.

DEA 61

DEA Marijuana History THC 61

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. On Monday, the U.S.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MassRoots

NOVEMBER 19, 2018

The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. each year to help them get rid of illegal cannabis grows. The DEA Administrator should clearly document all DCE/SP program goals.

DEA 64

DEA Programs Marijuana Collective 64

Cannabis Law Report

AUGUST 24, 2020

August 24, 2020 The DEA has not issued a warning or otherwise signaled a change in enforcement policy by issuing the interim final rule. The post Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp first appeared on Cannabis Law Report. On … Read More.

DEA 59

DEA Hemp Marijuana Policy 59

Cannabis Law Report

MARCH 10, 2021

Marijuana Moment reports A Seattle doctor hoping to expand access to psilocybin mushrooms for terminally ill cancer patients is taking… Read More. The post USA: Dr Suing DEA Over Right To Give Patients Psilocybin Treatment first appeared on Cannabis Law Report.

DEA 85

DEA Treatment Patients Access 85

Canna Law Blog

AUGUST 24, 2020

On Friday, the Drug Enforcement Administration (“DEA”) released an Interim Final Rule (the “ Rule ”) that, as we discussed , threatens the hemp industry by treating partially processed hemp extract not intended for consumption (also known as “intermediary hemp”) as a Schedule I controlled substance.

DEA 88

DEA THC Sativa Hemp 88

Cannabis Law Report

MARCH 21, 2020

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. This proposed rule will result in additional registered growers and a larger, more diverse variety of marijuana available for research.

DEA 97

DEA Marijuana Extraction Programs 97

CannaMD

JULY 19, 2020

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. At the same time, however, the number of illegal cannabis plants seized by the agency spiked. Let’s take a closer look at what DEA data reveals. Cannabis Users Left Alone. Illicit Grow Ops Targeted.

DEA 59

DEA Marijuana Data Decriminalization 59